No Data
Montage Technology's net profit for 2024 is expected to increase by over 200%. In Q4, multiple data points hit record highs, driven by the AI boom, leading to new product shipments.
Montage Technology expects to achieve a net income of 1.378 billion to 1.438 billion yuan for the fiscal year 2024, representing year-on-year growth of 205.62% to 218.93%; The company announced the launch of its latest developed PCIe 6.x/CXL 3.x Retimer chip, which has been successfully delivered to customers for sampling.
The semiconductor material manufacturer Xinyi Technology has started the A-share IPO counseling, with Tuojing Technology and Advanced Micro-Fabrication Equipment Inc. China both investing.
① Xinmi Technology has completed the listing counseling filing and intends to go public on the A-shares, with Sinolink serving as the counseling institution; ② The strategic financing completed by Xinmi Technology in May 2023 was jointly invested by the leading domestic film deposition equipment company Tuojing Technology and the leading company in the Semiconductors etching equipment, Advanced Micro-Fabrication Equipment Inc. China.
Only 6.6% away! Semiconductor Manufacturing International Corporation aims for a historical high, nearly 600 stocks have hit record highs this year, these stocks have created historical trading volumes.
① Today, Semiconductor Manufacturing International Corporation surged by 6.3%, with the intraday stock price reaching a new high in nearly two months, approaching the previously recorded all-time high. ② Currently, the financing balance of Semiconductor Manufacturing International Corporation remains at a historical high, but has recently decreased significantly, with a cumulative Shareholding of 2.1 billion yuan in the past month. ③ A total of over 590 stocks reached a new high this year today, with 43% of stocks also recording the highest trading volume for the year, among which 7 stocks simultaneously hit historical peak trading volumes.
Firing the first shot for increased computing power! Driven by CPU and DCU, Haiguang Information's annual report shows net profit may increase by nearly 60%.
① Haiguang Information expects to achieve revenue of 8.72 billion to 9.53 billion yuan in 2024, a year-on-year increase of 45.04% to 58.52%; ② Regarding the reasons for performance growth, Haiguang Information stated that the rapid iteration and development of DCU products has achieved support for AI industry applications such as commercial computing.
An alternative "going abroad" for centralized procurement of pharmaceuticals and medical devices? The China-ASEAN regional centralized procurement platform for pharmaceuticals has been launched, and the industry anticipates the birth of the first Order.
① Today, the China-ASEAN pharmaceutical regional procurement platform officially launched, with representatives from Shenzhen Mindray Bio-Medical Electronics, United Imaging Healthcare, SIMCERE PHARMA, and other companies present; ② Although the specific implementation plan is yet to be clarified, the industry believes it is undoubtedly Bullish for domestic pharmaceutical companies; ③ The Southeast Asian pharmaceutical market is growing rapidly, but it relies heavily on imported drugs and medical devices.
The A-shares collectively fell, with the Northern Stock Exchange 50 dropping nearly 1%, Hong Kong stocks tumbled, Semiconductor Manufacturing International Corporation and Xiaomi both fell over 1%, and the yuan's central parity rate continues to hold firm
The central exchange rate of the RMB against the US dollar is reported at 7.1887, down 8 points; the previous trading day's central rate was 7.1879, and the official closing price on the previous trading day was 7.3275, while the overnight market reported a close of 7.3284. Treasury Futures declined.